Search Results - "Dalhoff, K"

Health consequences of androgenic anabolic steroid use by Horwitz, H., Andersen, J. T., Dalhoff, K. P.

“…Background The lifetime prevalence of androgenic anabolic steroid abuse is estimated to be around 6% for men, but there is limited knowledge about the side…”
Get full text

The Mossman–Pacey Paradox by Horwitz, H., Dalhoff, K. P., Andersen, J. T.

“…Click here to view the view the Letter by Dr. Mossman and Dr. Pacey…”
Get full text

Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy by Eliasen, Astrid, Kornholt, J, Mathiasen, R, Brok, J, Rechnitzer, C, Schmiegelow, K, Dalhoff, K

“…Introduction Despite treatment with antiemetic medications, nausea remains uncontrolled for many children receiving chemotherapy. One reason is that risk…”
Get full text

Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment by Kothe, H, Bauer, T, Marre, R, Suttorp, N, Welte, T, Dalhoff, K, Competence Network for Community-Acquired Pneumonia study group

“…Community-acquired pneumonia remains a major cause of mortality in developed countries. There is much discrepancy in the literature regarding factors…”
Get full text

Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia by Gregers, J, Gréen, H, Christensen, I J, Dalhoff, K, Schroeder, H, Carlsen, N, Rosthoej, S, Lausen, B, Schmiegelow, K, Peterson, C

“…The membrane transporter P-glycoprotein, encoded by the ABCB1 gene, influences the pharmacokinetics of anti-cancer drugs. We hypothesized that variants of…”
Get full text

Higher chlorzoxazone clearance in obese children compared with nonobese peers by Gade, C., Dalhoff, K., Petersen, T. S., Riis, T., Schmeltz, C., Chabanova, E., Christensen, H. R., Mikus, G., Burhenne, J., Holm, J. C., Holst, H.

“…Aims To test the in vivo activity of Cytochrome P450 (CYP) 2E1 in obese children vs. nonobese children, aged 11–18 years. Secondly, whether the activity of…”
Get full text

Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade by Braeken, D. C. W., Essig, A., Panning, M., Hoerster, R., Nawrocki, M., Dalhoff, K., Suttorp, N., Welte, T., Pletz, M. W., Witzenrath, M., Rohde, G. G. U., Rupp, J.

“…To determine the most relevant pathogens for CAP in Germany, patients with radiologically confirmed pulmonary infiltrates and at least one clinical sign of…”
Get full text

Challenges in conducting paediatric trials with off-patent drugs by Haslund-Krog, S.S., Jorgensen, I.M., Henriksen, T.B., Dalhoff, K., Debes, N.M., van den Anker, J., Holst, H.

“…For more than two decades several initiatives have emerged to increase recruitment of paediatric patients in drug trials. While trials of newly approved drugs…”
Get full text

Methylphenidate misuse in adult patients and the impact of therapeutic use by Jensen, L S, Pagsberg, A K, Dalhoff, K

“…Methylphenidate (MPH) prescription rates for adults increase, but the extent of a parallel rise in toxic exposures and their causes and distribution between…”
Get more information

Urine and serum concentrations of inhaled and oral terbutaline by Elers, J, Hostrup, M, Pedersen, L, Henninge, J, Hemmersbach, P, Dalhoff, K, Backer, V

“…We examined urine and serum concentrations after therapeutic use of single and repetitive doses of inhaled and supratherapeutic oral use of terbutaline. We…”
Get more information

Recommendations of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the Diagnosis and Treatment of Non-tuberculous Mycobacterioses by Schoenfeld, N, Haas, W, Richter, E, Bauer, T, Boes, L, Castell, S, Hauer, B, Magdorf, K, Matthiessen, W, Mauch, H, Reuss, A, Schenkel, K, Ruesch-Gerdes, S, Zabel, P, Dalhoff, K, Schaberg, T, Loddenkemper, R

“…Non-tuberculous mycobacterioses comprise a group of diseases caused by mycobacteria which do not belong to the Mycobacterium (M.) tuberculosis-complex and are…”
Get more information

Individual pharmacokinetic variation leads to underdosing of ciprofloxacin in some cystic fibrosis patients by Schultz, A.N.Ø., Høiby, N., Nielsen, X.C., Pressler, T., Dalhoff, K., Duno, M., Buchard, A., Johansen, H.K., Wang, H., Dalbøge, C.S.

“…Summary Background: Ciprofloxacin (CIP) is frequently used when treating cystic fibrose (CF) patients with intermittent Pseudomonas aeruginosa (P. aeruginosa)…”
Get full text

Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants by Lyauk, YK, Stage, C, Bergmann, TK, Ferrero‐Milliani, L, Bjerre, D, Thomsen, R, Dalhoff, KP, Rasmussen, HB, Jürgens, G

“…The aim of this study was to identify demographic and genetic factors that significantly affect methylphenidate (MPH) pharmacokinetics (PK), and may help…”
Get full text

Acute Renal Failure Associated with Tenofovir Treatment in a Patient with Acquired Immunodeficiency Syndrome by Schaaf, B., Aries, S. P., Kramme, E., Steinhoff, J., Dalhoff, K.

“…We report a case of acute renal failure due to proximal tubular necrosis associated with tenofovir treatment in a patient with acquired immunodeficiency…”
Get full text

Chlamydia pneumoniae is frequently detected in the blood after acute lung infection by Witte, L, Droemann, D, Dalhoff, K, Rupp, J

Get full text

Randomized Phase III Study of Gemcitabine and Vinorelbine Versus Gemcitabine, Vinorelbine, and Cisplatin in the Treatment of Advanced Non-Small-Cell Lung Cancer: From the German and Swiss Lung Cancer Study Group by LAACK, E, DICKGREBER, N, KORTSIK, C, GRAEVEN, U, BURK, M, DIERLAMM, T, WELTE, T, BURKHOLDER, I, EDLER, L, HOSSFELD, D. K, MÜLLER, T, KNUTH, A, BENK, J, LORENZ, C, GIESELER, F, DÜRK, H, ENGEL-RIEDEL, W, DALHOFF, K

“…To evaluate whether cisplatin-based chemotherapy (gemcitabine, vinorelbine, and cisplatin [GVP]) prolongs overall survival in comparison to cisplatin-free…”
Get full text

Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia by Schaaf, B, Kruse, J, Rupp, J, Reinert, R. R, Droemann, D, Zabel, P, Ewig, S, Dalhoff, K

“…Easily performed prognostic rules are helpful for guiding the intensity of monitoring and treatment of patients. The aim of the present study was to compare…”
Get full text

A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma by DALHOFF, K, DANCEY, J, SKOV, T, BURCHARTH, F, EVANS, T. R. J, ASTRUP, L, SKOVSGAARD, T, HAMBERG, K. J, LOFTS, F. J, ROSMORDUC, O, ERLINGER, S, BACH HANSEN, J, STEWARD, W. P

“…Hepatocellular carcinoma (HCC) is a common malignant tumour, which has a poor prognosis. Surgical resection can be curative but most patients are inoperable…”
Get full text

Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission by Herrlinger, K.R, Noftz, M.K, Dalhoff, K, Ludwig, D, Stange, E.F, Fellermann, K

“…OBJECTIVES: Information on the occurrence and frequency of pulmonary involvement in patients with inflammatory bowel disease (IBD) is inconsistent. The aim of…”
Get full text

P29 A smartphone application to monitor nausea in pediatric cancer patients during chemotherapy by Eliasen, A, Abildtoft, MK, Krogh, NS, Brok, JS, Mathiasen, R, Schmiegelow, K, Dalhoff, KP

“…BackgroundNausea is a common and distressing side effect for children in chemotherapy. Antiemetic recommendations are based on limited literature and…”
Get full text